Printer Friendly
The Free Library
14,669,765 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Two APL trials provide mixed results.


Two clinical trials testing altered peptide ligands (APLs) in relapsing-remitting MS were halted ahead of schedule, because of side effects Side effects

Effects of a proposed project on other parts of the firm.
. In both studies, the APLs produced allergic reactions allergic reaction
n.
A local or generalized reaction of an organism to internal or external contact with a specific allergen to which the organism has been previously sensitized.
, and in one they may have actually triggered exacerbations (or attacks of MS symptoms). The disappointing findings were reported in the October 2000 issue of Nature Medicine.

APL (A Programming Language) A high-level mathematical programming language noted for its brevity and matrix generation capabilities. Developed by Kenneth Iverson in the mid-1960s, it runs on micros to mainframes and is often used to develop mathematical models.  therapy was thought to be of value because of the possibility that it could change "bad" inflammatory immune responses into "good" anti-inflammatory responses. Both studies confirmed that these bioengineered immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
 triggers do induce an immune response in MS. In one study, the APLs seemed to bring about the responses investigators had hoped for. In the other, the response did not appear to have been changed.

APL therapy may still have potential as a possible treatment for MS. However, further research is needed to determine how APLs affect immune function Immune function
The state in which the body recognizes foreign materials and is able to neutralize them before they can do any harm.

Mentioned in: Herbalism, Traditional Chinese, Stress Reduction
, and to clarify whether some individuals may be more responsive to them than others.
COPYRIGHT 2001 National Multiple Sclerosis Society
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:altered peptide ligands, multiple sclerosis
Publication:Inside MS
Date:Jan 1, 2001
Words:160
Previous Article:Avonex for people who might get MS?(multiple sclerosis)
Next Article:MARIE PERNA DARES TO DREAM.
Topics:



Related Articles
MS research makes the front page. (immunology of multiple sclerosis)(includes excerpt from New York Times)
Blocking multiple sclerosis in a mouse model.
Boning Up.
Rapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 Genome.(Statistical Data Included)
NEW TECHNOLOGY HELPS DRUG COMPANIES DESIGN SAFER DRUGS.(AxCell Biosciences)
Target: celiac disease: therapies aimed to complement or replace the gluten-free diet.
The biochemistry of what you feel.
Antiphospholipid syndrome: review.
PharmaDesign, Protosera Jointly Identify New Peptide Ligand and Receptor.
FDA CLEARS BIOMS MEDICAL FOR PHASE III MULTIPLE SCLEROSIS.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles